Antimicrobials Flashcards

1
Q

Static antimicrobials

A

slow or inhibit growth
Slower onset of axn
Require a functional immune system– not used in imcp’d
or life threatening situations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cidal

A

kills the microbes
Does not require a functional immune system– used in imcp’d and life-threatening situation.
Fast onset of axn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Situations to use broad-spectrums

A

1- Wide differential
2- waiting for identification would be dangerous
3- Tx of resistant pathogens to narrow spectrum compounds
4- polymicrobial infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Natural sources for antibiotics

A

Actinomycetes
Filamentous fungi
Soil bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Sulfonamides

A

Inhibitors of metabolism/Blocks NA synthesis
Synthetic antimicrobials
Block folic acid synthesis- they’re structural analogs of PABA (component of folic acid)

Used against bacteria bc humans don’t synthesize their own folic acid.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

TMP-SMX synergy

A

TMP (trimethoprim) blocks dihydrofolate reductase- inhibits nucleic acid synthesis

SMX (sulfamethoxazole) block dihydropteroate synthetase

Together they are v effective at inhibiting folic acid synthesis in bacteria.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cyclines

A

ex: Doxycycline
inhibit protein synthesis
Bind aminoacyl site of 30S– inhibits aminoacyl tRNA from binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Aminoglycosides

A

ex: Streptomycin

Interferes with formation of 30S initiation complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Macrolides

A

ex: Erythromycin

binds 23S component of 50S rRNA and blocks the exit of the peptide chain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

B-lactams

A

Inhibit PDG/cell wall synthesis
Includes: Penicillins, cephalosporins, monobactams, and carbapenems

All are only active on growing cells
No cross-linking of PDG– weakened cell wall– increased pressure with no support– lysis.

Does not work on mycoplasma bc they don’t have cell wall, or fungi, bc they don’t have PDG.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Mechanism of B-lactams

A

Antibiotic binds to PBPs involved in cross-linking the cells wall.
Blocks transpeptidation
Activates bacterial autolytic enzymes/removes autolysis inhibitor–> bacterial cell lyses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Quinolones and Fluoroquinolones

A

Inhibit nucleic acid synthesis
They are nalidixic acid analogs.

Ex: Ciprofloxacin (fluoroquinolone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

VRE

A

vancomycin resistant enterococci

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

KPC

A

Klebsiella pneumoniae carbapenemases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ESBL

A

Extended spectrum B-lactamases
Confer resistance to all B-lactam antibiotics (except cephamycins and carbapenems), and frequently many others like ahminoglycosides and fluoroquinolones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why are enterococci resistant to SMX-TMP?

A

bc they lack folic acid synthesis pathway.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Amino glycosides are ineffective against what?

A

Anaerobes, bc they lack oxidative phosphorylation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Glycopeptides are ineffective against what?

A

G-, bc they are too large to penetrate outer membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Nitroimidazoles are ineffective against what?

A

Aerobes, bc they lack flavodoxin which is required to activate nitroimidazoles.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Mechanisms of resistance

A

Altered uptake
Altered target
Drug inactivation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Altered uptake

A

prevents antibiotic intracellular accumulation to therapeutic level.

Often involves efflux pumps norm encoded by transposons, or membrane location transport proteins

Seen in G+ and G-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Altered target

A

mecA gene- encodes for PBP2a (modified transpeptidase) lowers binding affinity for B-lactam antibiotics. Transpeptidation still occurs.

Seen in S. aureus and S. pneumoniae spp.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Antibiotic inactivation

A

Hydrolytic enzymes cleave the antibiotic, making them inactive.
common in B-lactamase bacteria.
Solution: antibiotic with B-lactamase inhibitor (Clavulanic acid)

24
Q

Main ESBL producers

A

Enterobacteriacae:
E. coli (CTX-M enzymes)
Klebsiella spp.

25
Q

B-lactam antibiotics that ESBL aren’t resistant to

A

Cephamycins (cefoxitin and cefotetant)

Carbapenems

26
Q

Risks for ESBL exposure

A
long-term antibiotics
prolonged ICU stay
Nursing homes
Severe illness
Residence in institution with high use of 3rd-gen cephalosporins
Instrumentation or catheterization
27
Q

Why is AST performed?

A

To give reliable estimate of activity of 2+ antimicrobial agents against a pathogen

Predict likely outcome of therapy

Survey development of resistance among a normally susceptible population of organisms

Predict therapeutic potential

28
Q

Why use antibiograms?

A

To guide treatment in advance of individual susceptibility results

Helps institutions determine and track their susceptibility trends

29
Q

Mechanisms of resistance for a plasmid or transposom

A

1- Transformation (DNA binding proteins)
2- Conjugation (plasmid)
3- Transduction (bacteriophage)

30
Q

What happens to newly acquired DNA?

A

1- destruction by bacterial endonucleases
2- Circularization and maintenance as a plasmid
3- Recombination and integration

31
Q

Types of recombination

A

1- Homologous (general)

2- Non-homologous (site-specific): “cut and paste” mechanism. Transposition

32
Q

Homologous recombination

A

between similar/identical DNA

For integration of DNA acquire by: conjugation, transduction or transformation

33
Q

Transformation

A

Uptake of free-floating DNA.
Facilitated by DNA binding proteins on the bacterial cell membrane.
Requires Ca2+

34
Q

Conjugation

A

Only in G- bacteria
Reliant of sex pilus encoded by F factor (tra) plasmid.
Pilus brings F+ and F- cells into contact, F+ gives F- some DNA and then they’re both F+

MDR bacteria are normally plasmid encoded

35
Q

Transduction

A

Bacteriophage injects DNA into host bacterial cell.

36
Q

Transposition

A

Mobile genetic elements Tn or IS are transferred between bacteria– helps confer resistance.

37
Q

Fluoropyrimidine analogs

A

Target nucleic acid synthesis in fungi.

Flucytosin= artificial pyrimidine.
Causes intracellular deamination by fingal cytosine deaminase to 5-fluorouracil– inhibits NA synthesis

Works against: Candid, cryptococcus fungi

anti-protozoal against” Leishmania, and acanthamoebae

38
Q

Polyenes

A

Target ergosterol synthesis
Lipophilic
Ex: amphotericin B
Binds ergosterol in fungal cell membrane– disrupts osmotic integrity–> ion leakage and membrane destabilization –> lyses the cell.

Fungicidal against most yeasts and filamentous fungi

Anti-protozoal against amoebas

39
Q

Azoles

A

Target ergosterol synthesis by inhibiting 14a-demethylase (converts lanosterol to ergosterol)

Most widely used antifungal

Imidazole’s (2Ns): Ketoconazole
Triazoles (3Ns): Fluconazole, Voriconazole
have reduced toxicity and higher efficacy to imidazoles
Can be fungicidal or fungistatic

40
Q

Terbinafine

A

an Allylamine anti fungal often in topical creams

Inhibits squalene epoxidase–> squalene can’t be converted to lanosterol–> can’t form ergosterol

41
Q

Echinocandins

A

Inhibit chitin synthesis

ex: Caspofungin

Block (1,3)-B-D-glucan synthetase involved in chitin formation

42
Q

Resistance to azoles

A

due to:
Efflux mediated by multi drug transporters
Mutations that decrease affinity to the fungi
Upregulation of demthylase
Alteration in the ergosterol biosynthetic pathway

43
Q

Neuraminidase inhibitors

A

Target viral release (influenza virus)
Ex: Osteltamivir
Blocks neuraminidase –> virus forms aggregates at cell surface and their release is blocked

44
Q

IFNs as anti-virals

A

Both Type I and type II IFNs stimulate uninfected cells to produce antiviral proteins.

Produced in response to:

  • live virus
  • inactivated virus
  • viral nucleic acids

IFN-a2b used for chronic Hep C
IFN-a used against Hep B
IFN-a-n3 used against genital and perianal HPV warts.

45
Q

Adamantanes

A

Antivirals that inhibit uncoating
Ex: Amantadine
Blocks M2 ion channel– viral RNAs then remain bound to M1 and can’t enter the nucleus. Viral replication is halted.

46
Q

Integrase strand transfer inhibitors (INSTIs)

A

Antiretrovirals, target viral synthesis
Ex: Raltegravir, Elvitegravir
Inhibits viral DNA from combining to integrase which blocks it from bonding with the host DNA.

47
Q

NRTIs and NtRTIs

A

anti-virals. Reverse transcriptase inhibitors

Both lack 3-hydroxyl group (have N3 instead). Incorporation into DNA results in chain termination. Aka inhibits DNA synthesis.

48
Q

Acyclovir

A

NRTI (nucleoside analog reverse transcriptase inhibitor)

Requires intracellular phosphorylation to a triphosphate form.

Selective toxicity against viral thymidine kinase. Causes chain termination

Activity against: HSV-1 and HSV-2

49
Q

Viral load

A

measures treatment efficacy

Most frequently used to monitor antiretroviral therapy

50
Q

Nitazoxanide

A

Thiazolide. Interferes with pyruvate ferredoxin oxidoreductase.

Activity against:
Helminths
  - nematodes
  - cestodes
  - trematodes
Protozoa (guardia, cryptosporidium)
  - interferes w anaerobic metabolism
51
Q

Nitroimidazoles

A

Anti-protozoal and anti-bacterial for anaerobes.

Ex: Metronidazole
Causes DNA damage and strand breakage– loss of helical structure, impaired ability to act as template.

52
Q

Pentamidine

A

Interferes w NA and protein synthesis

Anti-fungal (P. jirovecii)
Antiprotozoa (giardiasis, cryptospoirodsis)
Toxic with lots of side effects

53
Q

Antimalarials

A

Quinines: interferes with parasite’s hematin detoxification. Targets blood schizontocides
- chloroquine, mefloquine, quinine

Protein synth inhibitors: Inhibits 70S ribosomes and apicoplast. Targets blood and liver stages.
- Doxycycline

Sesquiterpenes: Artemisinin. Release free-radicals into parasite vacuoles and damage membranes. Inhibits metab processes (glycolysis)

54
Q

Ivermectin

A

Anti-helminthic
Interferes with glutamate gated Cl- channel–> disrupts neural and neuromuscular transmission.

Acts against: nematodes, cestodes and trematodes.
For: onchocerciasis and lymphatic filariasis

55
Q

Benzimidazoles

A

Anti-helminthic.
Binds Beta-tubulin, and inhibits polymerization, glucose transport and fumarate reductase

Exs: Albendazole, Mebendazole

Activity against intestinal nematodes and cestode spp.

56
Q

Praziquantel

A

Anti-helminthic
Interferes with calcium transport (tegument). Causes worm paralysis –> detachment, breakdown and expulsion.

Activity against: trematodes and cestodes.
Tx for: schistosomiasis, liver flukes and cysticercosis.